Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
Sell
29
MED Quote, Financials, Valuation and Earnings
Last price:
$13.84
Seasonality move
:
15.81%
Day range:
$13.69 - $14.04
52-week range:
$13.48 - $39.00
Dividend yield:
0%
P/E ratio:
76.83x
P/S ratio:
0.25x
P/B ratio:
0.72x
Volume:
137.7K
Avg. volume:
237.2K
1-year change:
-63.91%
Market cap:
$151.3M
Revenue:
$602.5M
EPS (TTM):
$0.18
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Revenue Growth (YoY) | 30.99% | 63.25% | 4.75% | -32.94% | -43.8% | |
| Cost of Revenues | $237M | $398.5M | $458.2M | $296.2M | $157.8M | |
| Gross Profit | $697.8M | $1.1B | $1.1B | $775.9M | $444.6M | |
| Gross Profit Margin | 74.65% | 73.89% | 71.34% | 72.37% | 73.8% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | |
| Other Inc / (Exp) | -$140K | $119K | -$46K | -$95K | -$3.9M | |
| Operating Expenses | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | |
| Operating Income | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Net Interest Expenses | -- | $231K | $701K | -- | -- | |
| EBT. Incl. Unusual Items | $134.3M | $216.1M | $184.1M | $128.8M | $3.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $31.4M | $52.1M | $40.5M | $29.4M | $1.7M | |
| Net Income to Company | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Basic EPS (Cont. Ops) | $8.74 | $14.01 | $12.82 | $9.13 | $0.19 | |
| Diluted EPS (Cont. Ops) | $8.68 | $13.89 | $12.73 | $9.10 | $0.19 | |
| Weighted Average Basic Share | $11.8M | $11.7M | $11.2M | $10.9M | $10.9M | |
| Weighted Average Diluted Share | $11.9M | $11.8M | $11.3M | $10.9M | $11M | |
| EBITDA | $138.5M | $223.1M | $195.7M | $139.5M | $15.6M | |
| EBIT | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Revenue (Reported) | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Operating Income (Reported) | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Operating Income (Adjusted) | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $264.9M | $377.8M | $337.2M | $191M | $119M | |
| Revenue Growth (YoY) | 55.25% | 42.63% | -10.74% | -43.36% | -37.7% | |
| Cost of Revenues | $65.7M | $99.5M | $103.6M | $49.6M | $30.8M | |
| Gross Profit | $199.2M | $278.3M | $233.6M | $141.4M | $88.2M | |
| Gross Profit Margin | 75.21% | 73.65% | 69.27% | 74.01% | 74.13% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $161.3M | $231.4M | $201M | $132.7M | $87.5M | |
| Other Inc / (Exp) | -$152K | $7K | -$9K | -$50K | -$387K | |
| Operating Expenses | $161.3M | $231.4M | $201M | $132.7M | $87.5M | |
| Operating Income | $38M | $46.8M | $32.6M | $8.7M | $709K | |
| Net Interest Expenses | -- | $93K | $182K | -- | -- | |
| EBT. Incl. Unusual Items | $37.9M | $46.8M | $32.4M | $9.8M | $1.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.9M | $12.7M | $5.9M | $3.8M | $474K | |
| Net Income to Company | $28M | $34M | $26.5M | $6M | $801K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $28M | $34M | $26.5M | $6M | $801K | |
| Basic EPS (Cont. Ops) | $2.38 | $2.94 | $2.45 | $0.50 | $0.07 | |
| Diluted EPS (Cont. Ops) | $2.36 | $2.91 | $2.43 | $0.50 | $0.07 | |
| Weighted Average Basic Share | $11.8M | $11.6M | $10.9M | $10.9M | $10.9M | |
| Weighted Average Diluted Share | $11.9M | $11.7M | $11M | $10.9M | $11M | |
| EBITDA | $38M | $49.8M | $35.5M | $12M | $3.9M | |
| EBIT | $38M | $46.7M | $32.6M | $8.7M | $709K | |
| Revenue (Reported) | $264.9M | $377.8M | $337.2M | $191M | $119M | |
| Operating Income (Reported) | $38M | $46.8M | $32.6M | $8.7M | $709K | |
| Operating Income (Adjusted) | $38M | $46.7M | $32.6M | $8.7M | $709K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $237M | $398.5M | $458.2M | $296.2M | $157.8M | |
| Gross Profit | $697.8M | $1.1B | $1.1B | $775.9M | $444.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | |
| Other Inc / (Exp) | -$140K | $119K | -$46K | -$95K | -$3.9M | |
| Operating Expenses | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | |
| Operating Income | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Net Interest Expenses | -- | $231K | $702K | -- | -- | |
| EBT. Incl. Unusual Items | $134.3M | $216.1M | $184.1M | $128.8M | $3.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $31.4M | $52.1M | $40.5M | $29.4M | $1.7M | |
| Net Income to Company | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Basic EPS (Cont. Ops) | $8.74 | $14.02 | $12.81 | $9.08 | $0.18 | |
| Diluted EPS (Cont. Ops) | $8.69 | $13.89 | $12.71 | $9.06 | $0.18 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $139.4M | $223M | $195.7M | $139.5M | $15.6M | |
| EBIT | $134.2M | $216.2M | $184.7M | $126.4M | $2.9M | |
| Revenue (Reported) | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Operating Income (Reported) | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Operating Income (Adjusted) | $134.2M | $216.2M | $184.7M | $126.4M | $2.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.6B | $1.1B | $602.5M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $398.5M | $458.2M | $296.2M | $157.8M | -- | |
| Gross Profit | $1.1B | $1.1B | $775.9M | $444.6M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $911.4M | $955.6M | $649.4M | $441.7M | -- | |
| Other Inc / (Exp) | $119K | -$46K | -$95K | -$3.9M | -- | |
| Operating Expenses | $911.4M | $955.6M | $649.4M | $441.7M | -- | |
| Operating Income | $216.2M | $184.8M | $126.4M | $2.9M | -- | |
| Net Interest Expenses | $254K | $702K | $181K | -- | -- | |
| EBT. Incl. Unusual Items | $216.1M | $184.1M | $128.8M | $3.8M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $52.1M | $40.5M | $29.4M | $1.7M | -- | |
| Net Income to Company | $164M | $143.6M | $99.4M | $2.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $164M | $143.6M | $99.4M | $2.1M | -- | |
| Basic EPS (Cont. Ops) | $14.02 | $12.81 | $9.08 | $0.18 | -- | |
| Diluted EPS (Cont. Ops) | $13.89 | $12.71 | $9.06 | $0.18 | -- | |
| Weighted Average Basic Share | $46.8M | $44.8M | $43.5M | $43.7M | -- | |
| Weighted Average Diluted Share | $47.3M | $45.1M | $43.7M | $43.8M | -- | |
| EBITDA | $223M | $195.7M | $139.5M | $15.6M | -- | |
| EBIT | $216.2M | $184.7M | $126.4M | $2.9M | -- | |
| Revenue (Reported) | $1.5B | $1.6B | $1.1B | $602.5M | -- | |
| Operating Income (Reported) | $216.2M | $184.8M | $126.4M | $2.9M | -- | |
| Operating Income (Adjusted) | $216.2M | $184.7M | $126.4M | $2.9M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Short Term Investments | $10.8M | $5.4M | -- | $55.6M | $71.4M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $53.4M | $180M | $118.9M | $54.6M | $42.4M | |
| Prepaid Expenses | $6.4M | $945K | -- | $19.4M | $9.6M | |
| Other Current Assets | -- | $16.3M | $16.2M | $10.7M | -- | |
| Total Current Assets | $234.3M | $306.9M | $222.8M | $224M | $214.4M | |
| Property Plant And Equipment | $38.1M | $80.6M | $75.6M | $67.1M | $48.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.9M | $6.5M | $12.5M | $14.7M | $9.7M | |
| Total Assets | $276.1M | $398.3M | $316.2M | $309.9M | $284.2M | |
| Accounts Payable | $36.1M | $70.9M | $53.1M | $39.2M | $23.1M | |
| Accrued Expenses | $24.6M | $35.9M | $23.8M | $22.1M | $14M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.7M | $6.5M | $5.8M | $5.9M | $6.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $111.4M | $169.8M | $140.9M | $92.3M | $64.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $118.8M | $195.9M | $161.2M | $108.4M | $74.1M | |
| Common Stock | $12K | $12K | $11K | $11K | $11K | |
| Other Common Equity Adj | $41K | $111K | $24K | $248K | $180K | |
| Common Equity | $157.2M | $202.5M | $155M | $201.5M | $210.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $157.2M | $202.5M | $155M | $201.5M | $210.1M | |
| Total Liabilities and Equity | $276.1M | $398.3M | $316.2M | $309.9M | $284.2M | |
| Cash and Short Terms | $174.5M | $109.5M | $87.7M | $150M | $162.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Short Term Investments | $10.8M | $5.4M | -- | $55.6M | $71.4M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $53.4M | $180M | $118.9M | $54.6M | $42.4M | |
| Prepaid Expenses | $6.4M | $945K | -- | $19.4M | $9.6M | |
| Other Current Assets | -- | $16.3M | $16.2M | -- | -- | |
| Total Current Assets | $234.3M | $306.9M | $222.8M | $224M | $214.4M | |
| Property Plant And Equipment | $38.1M | $80.6M | $75.6M | $67.1M | $48.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.9M | $6.5M | $12.5M | $14.7M | $9.7M | |
| Total Assets | $276.1M | $398.3M | $316.2M | $309.9M | $284.2M | |
| Accounts Payable | $36.1M | $70.9M | $53.1M | $39.2M | $23.1M | |
| Accrued Expenses | $24.6M | $35.9M | $23.8M | $22.1M | $14M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.7M | $6.5M | $5.8M | $5.9M | $6.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $111.4M | $169.8M | $140.9M | $92.3M | $64.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $118.8M | $195.9M | $161.2M | $108.4M | $74.1M | |
| Common Stock | $12K | $12K | $11K | $11K | $11K | |
| Other Common Equity Adj | $41K | $111K | $24K | $248K | $180K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $157.2M | $202.5M | $155M | $201.5M | $210.1M | |
| Total Liabilities and Equity | $276.1M | $398.3M | $316.2M | $309.9M | $284.2M | |
| Cash and Short Terms | $174.5M | $109.5M | $87.7M | $150M | $162.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Depreciation & Amoritzation | $4.3M | $6.8M | $11M | $13.1M | $12.7M | |
| Stock-Based Compensation | $6.8M | $9.9M | $11.1M | $8.2M | $7.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$4.6M | -$126.7M | $61.2M | $64.3M | $12.2M | |
| Cash From Operations | $145.2M | $94.5M | $194.6M | $147.7M | $24.5M | |
| Capital Expenditures | $5.9M | $34.2M | $16.7M | $6.5M | $7.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3M | -$29.1M | -$11.4M | -$61M | -$26.5M | |
| Dividends Paid (Ex Special Dividend) | -$53.2M | -$63.9M | -$71.6M | -$73M | -$715K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$5.6M | -$62.1M | -$128M | -$7M | -$836K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$57.1M | -$125.1M | -$199.6M | -$79.8M | -$1.5M | |
| Beginning Cash (CF) | $77M | $163.7M | $104.2M | $87.7M | $94.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $86.8M | -$59.7M | -$16.4M | $6.8M | -$3.6M | |
| Ending Cash (CF) | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Levered Free Cash Flow | $139.3M | $60.3M | $177.9M | $141.2M | $17M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $28M | $34M | $26.5M | $6M | $801K | |
| Depreciation & Amoritzation | -$943K | $3M | $3M | $3.4M | $3.2M | |
| Stock-Based Compensation | $2.6M | $3.3M | $3M | $2.4M | $2.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$11.7M | -$50.4M | $26.4M | $3.6M | -$2.3M | |
| Cash From Operations | $19.8M | -$7.5M | $51.7M | $10.5M | -$4.9M | |
| Capital Expenditures | $2M | $11.6M | $9.1M | $946K | $2.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $570K | -$11.6M | -$9.1M | -$10.7M | -$19.4M | |
| Dividends Paid (Ex Special Dividend) | -$13.3M | -$17M | -$17.9M | -$18M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$19K | -$14.2M | -$6.4M | -$10K | -$1K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$13.1M | -$31.2M | -$24.3M | -$17.9M | -$1K | |
| Beginning Cash (CF) | $156.5M | $154.5M | $69.7M | $112.8M | $115.3M | |
| Foreign Exchange Rate Adjustment | -$18K | -$18K | -$363K | -$197K | -- | |
| Additions / Reductions | $7.3M | -$50.3M | $18.3M | -$18.1M | -$24.4M | |
| Ending Cash (CF) | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Levered Free Cash Flow | $17.8M | -$19.1M | $42.7M | $9.6M | -$7.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Depreciation & Amoritzation | $4.3M | $6.8M | $11M | $13.1M | $12.7M | |
| Stock-Based Compensation | $6.8M | $9.9M | $11.1M | $8.2M | $7.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$4.6M | -$126.7M | $61.2M | $64.3M | $12.2M | |
| Cash From Operations | $145.2M | $94.5M | $194.6M | $147.7M | $24.5M | |
| Capital Expenditures | $5.9M | $34.2M | $16.7M | $6.5M | $7.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3M | -$29.1M | -$11.4M | -$61M | -$26.5M | |
| Dividends Paid (Ex Special Dividend) | -$53.2M | -$63.9M | -$71.6M | -$73M | -$715K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$5.6M | -$62.1M | -$128M | -$7M | -$836K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$57.1M | -$125.1M | -$199.6M | -$79.8M | -$1.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $86.8M | -$59.7M | -$16.4M | $6.8M | -$3.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $139.3M | $60.3M | $177.9M | $141.2M | $17M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $164M | $143.6M | $99.4M | $2.1M | -- | |
| Depreciation & Amoritzation | $6.8M | $11M | $13.1M | $12.7M | -- | |
| Stock-Based Compensation | $9.9M | $11.1M | $8.2M | $7.4M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$126.7M | $61.2M | $64.3M | $12.2M | -- | |
| Cash From Operations | $94.5M | $194.6M | $147.7M | $24.5M | -- | |
| Capital Expenditures | $34.2M | $16.7M | $6.5M | $7.5M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$29.1M | -$11.4M | -$61M | -$26.5M | -- | |
| Dividends Paid (Ex Special Dividend) | -$63.9M | -$71.6M | -$73M | -$715K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$62.1M | -$128M | -$7M | -$836K | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$125.1M | -$199.6M | -$79.8M | -$1.5M | -- | |
| Beginning Cash (CF) | $716.3M | $353M | $471.6M | $415.2M | -- | |
| Foreign Exchange Rate Adjustment | $112K | -$67K | -$72K | $47K | -- | |
| Additions / Reductions | -$59.7M | -$16.4M | $6.8M | -$3.6M | -- | |
| Ending Cash (CF) | $656.7M | $336.5M | $478.3M | $411.7M | -- | |
| Levered Free Cash Flow | $60.3M | $177.9M | $141.2M | $17M | -- | |
Get MED Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MED
Sector
P/E ratio
76.83x
17.72x
PEG ratio
--
0.31x
P/B ratio
0.72x
1.62x
Price / LTM sales
0.25x
0.62x
Growth Metrics
MED
Sector
Revenue growth
-37.7%
2.13%
Earnings growth
-86%
3.45%
Revenue (5-year growth)
-3.33%
4.18%
Earnings forecast
-$0.16
$0.30
Profitability
MED
Sector
Profitability FY 2024
$444.6M
$548.4M
Return on invested capital
1.01%
5.55%
Return on assets
0.71%
3.55%
Return on equity
1.01%
8.35%
Earnings Date
Last Earnings Date
Feb
18
Next Earnings Date
Apr
29
Estimated Next Earnings Date
May
20
Balance Sheet
MED
Sector
Total cash
$162.3M
$152.3M
Short term investments
$71.4M
$49M
Total assets
$284.2M
$1.8B
Long term debt
--
$220.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Stocks Did Warren Buffett Just Buy?
In Q4 of last year, Warren Buffett added to or…
Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
